|Videos|August 2, 2021
Roundtable: Synthetic Control Arms and Regulatory/HTA Requirements
Author(s)Parexel
Advertisement
A roundtable discussing the opportunities that synthetic control arms offer for patients and product developers, and how to overcome potential barriers with the use of this burgeoning clinical trial model.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
FDA Approves Wegovy HD Injectable Under Accelerated Approval
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5